pSivida Corp. (Nasdaq: PSDV) announced that the New Drug Application for ILUVIEN for the treatment of chronic Diabetic Macular Edema ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE